251 related articles for article (PubMed ID: 26669972)
1. Genetic factors influencing the risk of multiple myeloma bone disease.
Johnson DC; Weinhold N; Mitchell J; Chen B; Stephens OW; Försti A; Nickel J; Kaiser M; Gregory WA; Cairns D; Jackson GH; Hoffmann P; Noethen MM; Hillengass J; Bertsch U; Barlogie B; Davis FE; Hemminki K; Goldschmidt H; Houlston RS; Morgan GJ
Leukemia; 2016 Apr; 30(4):883-8. PubMed ID: 26669972
[TBL] [Abstract][Full Text] [Related]
2. C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease.
Sonmez M; Kazaz N; Yucel B; Topbas M; Ucar F
Hematology; 2014 Jun; 19(4):213-6. PubMed ID: 24074513
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.
Johnson DC; Weinhold N; Mitchell JS; Chen B; Kaiser M; Begum DB; Hillengass J; Bertsch U; Gregory WA; Cairns D; Jackson GH; Försti A; Nickel J; Hoffmann P; Nöethen MM; Stephens OW; Barlogie B; Davis FE; Hemminki K; Goldschmidt H; Houlston RS; Morgan GJ
Nat Commun; 2016 Jan; 7():10290. PubMed ID: 26743840
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of OPG, RANKL and RANKL/OPG ratio in newly-diagnosed patients with multiple myeloma. Clinical correlations.
Goranova-Marinova V; Goranov S; Pavlov P; Tzvetkova T
Haematologica; 2007 Jul; 92(7):1000-1. PubMed ID: 17606458
[TBL] [Abstract][Full Text] [Related]
5. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.
Wang J; Lu K; Song Y; Zhao S; Ma W; Xuan Q; Tang D; Zhao H; Liu L; Zhang Q
PLoS One; 2015; 10(7):e0133964. PubMed ID: 26218592
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and Treatment of Myeloma-Related Bone Disease.
Gau YC; Yeh TJ; Hsu CM; Hsiao SY; Hsiao HH
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328533
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival.
Andersen NF; Vogel U; Klausen TW; Gimsing P; Gregersen H; Abildgaard N; Vangsted AJ
Eur J Haematol; 2015 Jan; 94(1):60-6. PubMed ID: 24954766
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
[TBL] [Abstract][Full Text] [Related]
10. Gene Polymorphisms in the RANKL/RANK/OPG Pathway Are Associated with Type 2 Diabetes Mellitus in Southern Han Chinese Women.
Duan P; Tu P; Si L; Hu W; Liu M; Liu J; Xue Y
Genet Test Mol Biomarkers; 2016 Jun; 20(6):285-90. PubMed ID: 27171030
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women.
Shang M; Lin L; Cui H
Clin Biochem; 2013 Oct; 46(15):1493-501. PubMed ID: 23531404
[TBL] [Abstract][Full Text] [Related]
12. Advances in the pathogenesis of multiple myeloma bone disease.
Hu C; Kuang C; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1403-1410. PubMed ID: 38044652
[TBL] [Abstract][Full Text] [Related]
13. Myeloma bone disease: Progress in pathogenesis.
Xi H; An R; Li L; Wang G; Tao Y; Gao L
Prog Biophys Mol Biol; 2016 Nov; 122(2):149-155. PubMed ID: 27496181
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.
Knevel R; de Rooy DP; Saxne T; Lindqvist E; Leijsma MK; Daha NA; Koeleman BP; Tsonaka R; Houwing-Duistermaat JJ; Schonkeren JJ; Toes RE; Huizinga TW; Brouwer E; Wilson AG; van der Helm-van Mil AH
Arthritis Res Ther; 2014 May; 16(3):R108. PubMed ID: 24886600
[TBL] [Abstract][Full Text] [Related]
15. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
Qiang YW; Chen Y; Stephens O; Brown N; Chen B; Epstein J; Barlogie B; Shaughnessy JD
Blood; 2008 Jul; 112(1):196-207. PubMed ID: 18305214
[TBL] [Abstract][Full Text] [Related]
16. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
[TBL] [Abstract][Full Text] [Related]
17. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.
Terpos E; Szydlo R; Apperley JF; Hatjiharissi E; Politou M; Meletis J; Viniou N; Yataganas X; Goldman JM; Rahemtulla A
Blood; 2003 Aug; 102(3):1064-9. PubMed ID: 12689925
[TBL] [Abstract][Full Text] [Related]
18. Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.
Tharabenjasin P; Pabalan N; Jarjanazi H; Jinawath N
Osteoporos Int; 2022 Mar; 33(3):563-575. PubMed ID: 34716467
[TBL] [Abstract][Full Text] [Related]
19. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
[TBL] [Abstract][Full Text] [Related]
20. Biology and treatment of myeloma related bone disease.
Terpos E; Christoulas D; Gavriatopoulou M
Metabolism; 2018 Mar; 80():80-90. PubMed ID: 29175022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
